| Lindsay Ann Varley, PHARMD | |
|
1665 Alpine Blvd, Alpine, CA 91901-3859 | |
| (619) 659-1085 | |
| Not Available |
| Full Name | Lindsay Ann Varley |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 1665 Alpine Blvd, Alpine, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396030656 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 64811 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Lindsay Ann Varley, PHARMD 9745 Lorraine Way Apt 102, Santee, CA 92071-5237 Ph: () - | Lindsay Ann Varley, PHARMD 1665 Alpine Blvd, Alpine, CA 91901-3859 Ph: (619) 659-1085 |
News Archive
A research team, with the participation of the University of Granada (UGR), has made some progress in determining the causes for glioblastoma multiforme (GBM), one of the most aggressive brain tumors known, to be resistant to the drugs currently used, which is one of the main limitations of its treatment.
Drug manufacturers may abandon the health law's provisions to close Medicare's so-called "doughnut hole" if the high court overturns the measure. Also, religious leaders press the Department of Health and Human Services to widen the religious exemption to the health law's birth control mandate.
In an analysis that included more than 40,000 women exposed to the nausea medication metoclopramide in pregnancy, use of this drug was not associated with significantly increased risk of major congenital malformations overall, spontaneous abortion, and stillbirth, according to a study in the October 16 issue of JAMA.
Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.
› Verified 4 days ago
Eva Susi Mulyawati, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1665 Alpine Boulevard, Alpine, CA 92101 Phone: 619-659-1085 Fax: 619-659-5738 | |
Jemma B Felix-john Charles, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1665 Alpine Blvd, Alpine, CA 91901 Phone: 619-659-1085 | |
Victor Norman Sell, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1385 Tavern Rd, Alpine, CA 91901 Phone: 619-445-6904 | |
Hoa Ma, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2955 Alpine Blvd, Alpine, CA 91901 Phone: 619-445-0601 | |
Mrs. Orly Shakked, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1385 Tavern Rd, Alpine, CA 91901 Phone: 619-445-6900 | |
Brianna Lai, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1385 Tavern Rd, Alpine, CA 91901 Phone: 619-445-6903 |